Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant
- PMID: 39329706
- PMCID: PMC11430646
- DOI: 10.3390/cells13181523
Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, often fatal lung disease characterized by tissue scarring and declining lung function. The MUC5B promoter polymorphism rs35705950, a significant genetic predisposition for IPF, paradoxically associates with better survival and slower disease progression than other IPF genotypes. This study investigates the potential paradoxical protective effects of this MUC5B variant in lung fibrosis. For this purpose, we developed a transgenic mouse model overexpressing the human MUC5B rs35705950 variant in the proximal large airways. Lung fibrosis was induced through subcutaneous injection of bleomycin. Results demonstrated significantly reduced lung fibrosis severity in transgenic mice compared to wild-type mice, assessed by trichrome staining, Ashcroft scoring, and hydroxyproline levels. Additionally, transgenic mice showed significantly lower levels of inflammatory cells and cytokines (TNFα, IL-6, IFNγ) and growth factors (PDGF, CTGF, IL-13) in the bronchoalveolar lavage fluid and lung tissues. There was also a significant decrease in mRNA expressions of fibrosis-related markers (periostin, fibronectin, Col1a1). In summary, this study reveals that mucin overexpression related to the MUC5B rs35705950 variant in the large airways significantly attenuates lung fibrosis and inflammatory responses in transgenic mice. These findings suggest that the rs35705950 variant modulates inflammatory and fibrotic responses in the proximal airways, which may contribute to the slower disease progression observed in IPF patients carrying this variant. Our study offers a possible explanation for the paradoxical beneficial effects of the MUC5B variant despite its role as a significant predisposing factor for IPF.
Keywords: MUC5B; inflammation; pulmonary fibrosis; rs35705950.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice.Nat Commun. 2018 Dec 18;9(1):5363. doi: 10.1038/s41467-018-07768-9. Nat Commun. 2018. PMID: 30560893 Free PMC article.
-
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L1-L10. doi: 10.1152/ajplung.00395.2017. Epub 2018 Mar 22. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 29565179 Free PMC article.
-
Epithelial Endoplasmic Reticulum Stress Enhances the Risk of Muc5b-associated Lung Fibrosis.Am J Respir Cell Mol Biol. 2023 Jan;68(1):62-74. doi: 10.1165/rcmb.2022-0252OC. Am J Respir Cell Mol Biol. 2023. PMID: 36108173 Free PMC article.
-
Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S192-S197. doi: 10.1513/AnnalsATS.201802-144AW. Ann Am Thorac Soc. 2018. PMID: 30431344 Free PMC article. Review.
-
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.Physiol Rev. 2016 Oct;96(4):1567-91. doi: 10.1152/physrev.00004.2016. Physiol Rev. 2016. PMID: 27630174 Free PMC article. Review.
References
-
- Baratella E., Ruaro B., Giudici F., Wade B., Santagiuliana M., Salton F., Confalonieri P., Simbolo M., Scarpa A., Tollot S., et al. Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis. Diagnostics. 2021;11:762. doi: 10.3390/diagnostics11050762. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous